Granulocyte-colony stimulating factor enhances chimeric antibody Nd2 dependent cytotoxicity against pancreatic cancer mediated by polymorphonuclear neutrophils.

International journal of oncology

Volumn 21, Issue 3, 2002, Pages 649-654

  Tamamori, Yutaka ^a   Sawada, Tetsuji ^a   Nishihara, Tamahiro ^a   Yamashita, Yoshito ^a   Ohira, Masaichi ^a   Ho, Jenny J L ^a   Kim, Young Sik ^a   Hirakawa Y S Chung, Kosei ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; MONOCLONAL ANTIBODY;

ANIMAL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; BAGG ALBINO MOUSE; CELL CULTURE; DRUG EFFECT; DRUG POTENTIATION; DRUG SCREENING; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; METHODOLOGY; MOUSE; NEUTROPHIL; NUDE MOUSE; PANCREAS TUMOR;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; DRUG SYNERGISM; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOTHERAPY; MICE; MICE, INBRED BALB C; MICE, NUDE; NEUTROPHILS; PANCREATIC NEOPLASMS; RECEPTORS, FC; RECEPTORS, IGG; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MLCS; MLOWN;

EID: 0036730024     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.21.3.649     Document Type: Article

References (0)